Delivery Order SPE2DB24D2101-SPE2DB25FKMTY
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed price delivery order valued at $6,636.12 by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with a completion date of June 2, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries...
- The Defense Logistics Agency awarded a delivery order valued at $3,050.40 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $11,831.93 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pens on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a single delivery order fulfillment for pharmaceutical supplies to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. The contract, which is not set-aside and operates under firm fixed pricing, is scheduled for completion by September 2, 2025. AmerisourceBergen will perform this work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $13,836.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $5,630.51 delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This firm fixed price contract, with an ultimate completion date of August 11, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was made on a competitive basis without any set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $36,746.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectables. The contract, which represents a child order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $2,465.15 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pens on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed price, non-set-aside contract represents a small-value pharmaceutical delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive...
- The Defense Logistics Agency awarded a delivery order valued at $22,965.91 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $27,721.55 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 29, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 2, 2025, and involves performance at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a discrete fulfillment under AmerisourceBergen's larger pharmaceutical supply relationship with the federal...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMTYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,143.87 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen pharmaceutical supplies. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger Indefinite Delivery Contract vehicle, enabling the pharmaceutical distributor to fulfill federal medical procurement requirements for defense and military healthcare systems. This award falls under AmerisourceBergen's existing IDC with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support contract running through December 2026. As a major pharmaceutical distributor serving federal medical supply chains, AmerisourceBergen provides a broad range of medications, vaccines, and medical devices to support military healthcare programs and other government healthcare systems. The contract award reflects the company's established capability to meet competitive federal procurement standards and deliver specialized pharmaceutical products necessary for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/25/25 |